Bionyra Pharma
Bionyra Pharma develops biologic therapies for severe immunological and inflammatory diseases.
$165MSeries A
Role not disclosedSD
Sixty Degree Capital
Activity from announced rounds
Activity in this selectionEnterprise software
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $213M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionEclypsium
Provides supply chain security for IT infrastructure
$25MSeries C+
Role not disclosedHawkEye 360
Detects, geolocates, and characterizes RF signals using a commercial satellite constellation
$23MSeries E
Role not disclosed